Team StartupCity

• PlatinumRx raises $6M to offer cheaper, high quality generic medicines.
• Startup claims to cut medicine bills by 50-60% for chronic care patients.
• Targets 1 million customers by 2026 with AI and supply chain expansion.

PlatinumRx, a Bengaluru based online pharmacy, is taking on India’s expensive branded generics market. The young startup has raised $6 million in Series A funding led by Stellaris Venture Partners. It aims to slash monthly medicine bills for chronic care patients by offering trusted, low cost generic substitutes.

For millions of Indians living with diabetes, hypertension, or other chronic conditions, monthly drug costs can go as high as Rs 5,000. It is a major burden for middle class households. Although these medicines are technically generics, they are sold under brand names at steep markups, often up to six times the base cost.

PlatinumRx, launched in 2024 by Ashutosh Pandey and Piyush Kumar, offers one vetted alternative per salt, cutting through the confusing maze of branded generics. The platform only lists medicines that pass strict quality checks and are sourced directly from manufacturers. By doing so, it claims to reduce medicine bills by 50-60%.

The company currently operates two fulfilment centers in Bengaluru and Delhi and delivers across more than 20,000 pincodes. Its core markets include Uttar Pradesh, Maharashtra, Delhi, Karnataka, and West Bengal, which account for 60% of its orders. So far, it has served over 200,000 patients, with 60% of its customer base coming from metros and tier-1 cities.

Also Read: Is It Safe to Order Medicines Online?

With the fresh funding, PlatinumRx plans to build more fulfilment centers, grow its tech and product teams, and use AI to personalize medicine suggestions. It aims to reach one million customers in the next year.

While established players like Tata 1mg and Apollo 24/7 dominate the broader online pharmacy space, PlatinumRx stands out by focusing only on chronic care and trusted generics. Its narrow but deep strategy relies on quality, trust, and affordability not just discounts.

Stellaris believes this focused model could disrupt the traditional pharma supply chain and help more families access essential medicines without breaking the bank.